Uganda's Radiotherapy Queue Ends Where Palliative Care Begins
Uganda's only public radiotherapy centre sits in Kampala, and the queue for it is where a curable cervical cancer diagnosis often turns into a palliative one. This is what that pathway looks like from the districts, and what families can realistically do inside it.
The Radiotherapy Gap in Uganda
The Uganda Cancer Institute in Kampala is the country's sole public provider of radiotherapy, and it carries the referral load for the entire public system. Clinicians there have described waiting times that routinely exceed six weeks, with some patients waiting considerably longer depending on machine availability and the type of treatment planned.
That single-centre concentration matters most for cervical cancer, which is the most common cancer among Ugandan women and one of the few where radiotherapy is genuinely curative when delivered at the right stage. A woman diagnosed at a district hospital in the east or north is typically referred to Kampala, and the clock starts running the moment she leaves.
The phrase clinicians use is that the radiotherapy queue ends where palliative care begins. It describes a handoff that happens not because the cancer is untreatable, but because the treatment cannot be reached in time. The two services sit in the same building and serve opposite purposes.
A Patient's Journey from Mbale
Mbale Regional Referral Hospital, in eastern Uganda, diagnoses cervical cancer regularly. What it cannot do is treat it with radiation. A positive biopsy there typically triggers a referral letter to Kampala, roughly a five-hour drive on a good day, and that is the point where the pathway usually stalls.
The costs are cumulative and mostly informal. Transport for the patient and often a family member, accommodation in Kampala for the duration of treatment, food, and the lost income from weeks away from a farm or market stall. None of this appears on a referral form, and none of it is covered by the treatment itself.
While the family arranges money and travel, the tumour does not wait. Bleeding, pain, and discharge progress, and by the time a patient reaches the radiotherapy planning stage, the disease may have moved beyond the stage where radiation alone offers a cure. This is the delay that turns a treatable diagnosis into a terminal one.
Consider a woman in her forties from a village near Mbale who was diagnosed with stage IIB cervical cancer. She was given a referral letter and told to go to Kampala. Her family spent two weeks raising money for transport and a place to stay. By the time she reached the Uganda Cancer Institute, her disease had progressed to stage IIIB, and the curative window had closed. She was offered palliative radiotherapy and pain control. This pattern is not unusual; it is the norm for patients who must travel long distances.
Evidence on Treatment Delays
The relationship between waiting time and survival in cervical cancer is well established in the international literature. Delays beyond roughly eight weeks from diagnosis to the start of radiotherapy are associated with measurably worse outcomes, and studies from comparable settings have reported survival reductions in the range of 10 to 20 percent.
Ugandan-specific data on this is thinner than it should be. What exists comes largely from single-institution series and clinical observation rather than national registries, which means the figures are indicative rather than definitive. The direction of the effect is consistent across the studies that do exist, even where the magnitude is uncertain.
This pattern is not unique to cancer. A related piece on this site describes how midwives in Mozambique detect eclampsia before referral roads open, and the underlying problem is the same one: the diagnosis is made, and the treatment is somewhere else.
When the delay pushes a patient past the curative window, the clinical team's task changes. Radiation may still be offered for symptom control, but the goal shifts from cure to comfort, and palliative care becomes the organising framework rather than an add-on.
Palliative Care as Safety Net
Hospice Africa Uganda has been the backbone of the country's palliative care response since the early 1990s, and it is one of the few African organisations with a long track record of distributing oral morphine at scale. Its model relies on trained nurses and community volunteers who visit patients at home, which matters enormously when the patient lives hours from Kampala.
Oral morphine is inexpensive and effective for cancer pain, and Uganda was an early mover in allowing nurses with additional training to prescribe it. In practice, access remains uneven. Fears about diversion and addiction, held by some health workers and families alike, still restrict prescribing, and supply interruptions at district level are common.
Stigma compounds the problem. A cancer diagnosis in many communities carries a sense of hopelessness, and families sometimes conceal it, which delays both pain relief and honest conversations about what treatment can still achieve. Training gaps among general health workers mean palliative care is often not raised until very late, if at all.
The site has argued elsewhere that burnout surveys measure distress better than staffing, and the same caution applies here: workforce numbers alone do not capture whether a nurse has the time and support to manage a dying patient's pain properly.
A further complication is the tension between curative and palliative goals when a patient is still waiting for radiotherapy. Some clinicians are reluctant to start morphine early, fearing it signals that cure has been abandoned. In practice, early palliative care alongside curative intent improves quality of life and may even extend survival, but that evidence comes from settings with better-resourced oncology services. The trade-off in Uganda is that scarce morphine supplies might be diverted from patients who are clearly terminal to those who still hope for a cure, a dilemma that district health officers must weigh with limited guidance.
What Can Be Done Now
Expanding radiotherapy capacity at the Uganda Cancer Institute is the obvious long-term fix, and it is genuinely underway in fits and starts, but machine installation, commissioning, and trained staff take years. In the interim, decentralising palliative care to regional referral hospitals would reach far more patients per shilling spent.
Referral pathways also need work. A patient leaving Mbale with a letter and no appointment date, no contact number, and no estimate of cost is being set up to fail. A functioning pathway would include a scheduled slot, a named contact, and written information about what the treatment will cost the family.
Transport and accommodation support is unglamorous and effective. Small grants covering bus fare and a few weeks of lodging in Kampala have kept patients in treatment in programmes that offer them, and the amount required is modest relative to the cost of a radiotherapy course.
The morphine barrier is the most tractable of all. It is a matter of training, supply chain, and clear prescribing guidance rather than new technology, and it could be addressed within existing budgets if the will were there.
Practical Steps for Patients and Families
Ask about palliative care at the point of diagnosis, not after treatment fails. In Uganda, this usually means asking the referring clinician directly whether a palliative care referral can be made in parallel with the radiotherapy referral, so that pain control is not contingent on the queue.
- Ask the district hospital or regional referral hospital whether oral morphine is stocked and who can prescribe it.
- Contact Hospice Africa Uganda or Mobile Hospice Mbarara to ask about home visits in your district.
- Get the referral in writing, with a contact name and number at the Uganda Cancer Institute, before travelling.
- Budget explicitly for transport, accommodation, and food for the patient and one companion, and ask whether any NGO can offset it.
- Ask the clinical team to state the goal of treatment plainly, so the family can plan around it.
None of this replaces the structural fix. It is what families can do while the queue remains what it is.
This article is informational and does not constitute personalised medical advice. Patients and families should consult qualified clinicians about their own situation.
